clarithromycin has been researched along with Delayed Hypersensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cužić, S; Eraković Haber, V; Ivetić Tkalčević, V; Kramarić, MD; Parnham, MJ | 1 |
| Beuth, J; Ko, HL; Peters, G; Pulverer, G; Roszkowski, K | 1 |
2 other study(ies) available for clarithromycin and Delayed Hypersensitivity
| Article | Year |
|---|---|
Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Azithromycin; Cell Degranulation; Clarithromycin; Dermatitis, Contact; Dexamethasone; Ear; Hypersensitivity, Delayed; Immunoglobulin E; Interferon-gamma; Interleukin-1beta; Interleukin-4; Mast Cells; Mice; Oxazolone; Skin; Tetradecanoylphorbol Acetate; Th2 Cells; Tumor Necrosis Factor-alpha | 2012 |
Comparative study on the macrolides erythromycin and clarithromycin: antibacterial activity and influence on immune responses.
Topics: Animals; Antibody Formation; Bacteria; Chemotaxis, Leukocyte; Clarithromycin; Erythromycin; Female; Granulocytes; Haemophilus influenzae; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulin G; Immunoglobulin M; Macrophages; Male; Mice; Mice, Inbred BALB C; Phagocytosis; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1990 |